# HoLox

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/holox

- Industry: Software
- Headquarters: Beijing, China
- Website: www.dongxitech.com
- Latest round: Series A (Mar 9, 2018)
- Investors on record: 1

## About

Established in 2016 and based in Beijing, China, HoLox is a  medical software company that operates a pharmacovigilance SaaS platform. The company has 200 employees and a core team with more than 10 years of experience in the pharmaceutical security industry. In April 2023, it raised series A+ funding from new investors.

The company has developed its own four pharmaceutical safety platforms, Holox® Clinical, Holox® Pharma, Holox® Vaccin, and Holox® RWE. Its pharmaceutical safety platform provides report collection, pharmaceutical data analysis, pharmaceutical safety risk warning, relevant pharmaceutical literature search, PSUR (Periodic safety update reports), and international industry standard queries.

## Funding rounds

- Series A, Mar 9, 2018 — CCB International Asset Management

## Investors

- CCB International Asset Management (https://capitalatlas.ai/funds/ccb-international-asset-management) — Series A